Safety of conventional systemic therapies for psoriasis on reproductive potential and outcomes. (Q38271334)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25424052 AND SRC:MED&resulttype=core&format=json

23 February 2020

review article

1 reference

title

Safety of conventional systemic therapies for psoriasis on reproductive potential and outcomes (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25424052 AND SRC:MED&resulttype=core&format=json

23 February 2020

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25424052 AND SRC:MED&resulttype=core&format=json

23 February 2020

Christopher Griffiths

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25424052 AND SRC:MED&resulttype=core&format=json

23 February 2020

author name string

Richard B Warren

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25424052 AND SRC:MED&resulttype=core&format=json

23 February 2020

Ulrich Mrowietz

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25424052 AND SRC:MED&resulttype=core&format=json

23 February 2020

publication date

30 January 2015

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25424052 AND SRC:MED&resulttype=core&format=json

Journal of Dermatological Treatment

23 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25424052 AND SRC:MED&resulttype=core&format=json

23 February 2020

volume

26

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25424052 AND SRC:MED&resulttype=core&format=json

23 February 2020

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25424052 AND SRC:MED&resulttype=core&format=json

23 February 2020

page(s)

329-334

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25424052 AND SRC:MED&resulttype=core&format=json

Potentially modifiable risk factors for adverse pregnancy outcomes in women with psoriasis.

23 February 2020

cites work

1 reference

https://api.crossref.org/works/10.3109/09546634.2014.991673

Psoriasis and pregnancy outcomes: a nationwide population-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/09546634.2014.991673

Cyclosporine A exposure during pregnancy in mice: effects on reproductive performance in mothers and offspring

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/09546634.2014.991673

Pregnancy outcome after cyclosporine therapy during pregnancy: a meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/09546634.2014.991673

Pregnancy outcome after renal allograft transplantation: 15 years experience

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/09546634.2014.991673

Pustular psoriasis of pregnancy treated with ciclosporin and high-dose prednisolone

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/09546634.2014.991673

Generalized pustular psoriasis of pregnancy successfully treated with cyclosporine.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/09546634.2014.991673

Cholestasis in pregnancy associated with ciclosporin therapy in renal transplant recipients.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/09546634.2014.991673

Cyclosporine and psoriasis: 2008 National Psoriasis Foundation Consensus Conference

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/09546634.2014.991673

Treatment of psoriasis with fumaric acid esters (Fumaderm).

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/09546634.2014.991673

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/09546634.2014.991673

Methotrexate for psoriasis in the era of biological therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/09546634.2014.991673

Methotrexate-resistant form of dihydrofolate reductase protects transgenic murine embryos from teratogenic effects of methotrexate

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/09546634.2014.991673

Comparative ultrastructural alterations in rabbit limb‐buds after a teratogenic dose of either hydroxyurea or methotrexate

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/09546634.2014.991673

Teratogen update: methotrexate

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/09546634.2014.991673

Multiple congenital anomalies associated with weekly low-dose methotrexate treatment of the mother

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/09546634.2014.991673

Clinical teratology counseling and consultation case report: low dose methotrexate exposure in the early weeks of pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/09546634.2014.991673

Methotrexate exposure prior to and during pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/09546634.2014.991673

Developmental delay in fetal aminopterin/methotrexate syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/09546634.2014.991673

Multiple anomalies in a fetus exposed to low-dose methotrexate in the first trimester

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/09546634.2014.991673

Maternal and perinatal outcomes of first pregnancy after chemotherapy for gestational trophoblastic neoplasia in Brazilian women

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/09546634.2014.991673

The effects of methotrexate on pregnancy, fertility and lactation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/09546634.2014.991673

British Association of Dermatologists guidelines on the efficacy and use of acitretin in dermatology

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/09546634.2014.991673

Acitretin in psoriasis: an overview of adverse effects

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/09546634.2014.991673

Acitretin embryopathy: a case report

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/09546634.2014.991673

Severe limb defects and craniofacial anomalies in a fetus conceived during acitretin therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/09546634.2014.991673

Drug points: Successful breast feeding while mother was taking cyclosporin

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/09546634.2014.991673

Transfer of drugs and other chemicals into human milk

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/09546634.2014.991673

Effect of cyclosporine on fertility in male rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/09546634.2014.991673

Fertility preservation for young patients with cancer: who is at risk and what can be offered?

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/09546634.2014.991673

Is there a reproductive safety risk in male patients treated with acitretin (neotigason/soriatane?

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/09546634.2014.991673

The British Association of Dermatologists' Biologic Interventions Register (BADBIR): design, methodology and objectives.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/09546634.2014.991673

Teratogenic risk with etretinate and acitretin treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/09546634.2014.991673

Long-term outcome for patients with nonmetastatic osteosarcoma of the extremity treated at the istituto ortopedico rizzoli according to the istituto ortopedico rizzoli/osteosarcoma-2 protocol: an updated report

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/09546634.2014.991673